Track the 진원생명과학 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 진원생명과학 has published 60 reports. Market capitalisation: €9.7bn. The latest transaction was reported on 1 June 2026 (Other). Among the most active insiders: 박영근. Every trade is accessible without an account.
60
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
19 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Jinwon Life Sciences es una empresa de biotecnología centrada en el desarrollo de tratamientos para enfermedades infecciosas y cánceres. Cotiza en el mercado XKRX.